Sun closes in on Ranbaxy deal with CCI approval
The Competition Commission of India (CCI) has approved Sun Pharma’s $3.2bn acquisition of Ranbaxy.
Archives for December 10, 2014
US government offers legal immunity to Ebola vaccine manufacturers, CMOs
Manufacturers developing Ebola vaccines will be immune from lawsuits following a decision by US HHS (Health and Human Services) to issue a declaration on the matter.
Quintiles will continue to grow through acquisitions, says S&P
Quintiles has been upgraded to stable by ratings agency Standard & Poor after a second stock offering and the consolidation of debt through a $300m securitisation facility.
Medidata widening the gap on trial data competitors, say analysts
R&D investment and an integrated platform are widening the divide between Medidata and its competitors, according to analysts who are confident the trial data firm can achieve target sales of $1bn.
Foreign investment in UK drugmaking down; ABPI tasks ex-GSK exec with reversing trend
An ex-GSK staffer charged with winning manufacturing investments for the UK says fostering innovation and “fiscal attractiveness” are vital.
Want to work for Pfizer? Get ready for ‘American Idol’ audition
Pfizer has revealed a unique way of hiring employees in Sweden it compares to “American Idol” auditions.
Merck & Co set to be superbug-busting superstar despite US Cubicin ruling, analyst
Cubist will give Merck & Co leadership of the antibiotics sector according to one analyst who says renewed interest expressed by GSK, Roche and Sanofi has not produced any Ph III candidates.